MX354498B - Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida. - Google Patents
Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida.Info
- Publication number
- MX354498B MX354498B MX2014003638A MX2014003638A MX354498B MX 354498 B MX354498 B MX 354498B MX 2014003638 A MX2014003638 A MX 2014003638A MX 2014003638 A MX2014003638 A MX 2014003638A MX 354498 B MX354498 B MX 354498B
- Authority
- MX
- Mexico
- Prior art keywords
- imidazole
- hydroxy
- carboxamide
- hydrate
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011213500 | 2011-09-28 | ||
| JP2011213501 | 2011-09-28 | ||
| PCT/JP2012/075106 WO2013047758A1 (ja) | 2011-09-28 | 2012-09-28 | 5-ヒドロキシ-1h-イミダゾール-4-カルボキサミド水和物の結晶及び5-ヒドロキシ-1h-イミダゾール-4-カルボキサミド・3/4水和物の結晶及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014003638A MX2014003638A (es) | 2014-05-21 |
| MX354498B true MX354498B (es) | 2018-03-08 |
Family
ID=47995783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014003638A MX354498B (es) | 2011-09-28 | 2012-09-28 | Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9108928B2 (enExample) |
| EP (1) | EP2762469B1 (enExample) |
| KR (1) | KR101970509B1 (enExample) |
| CN (1) | CN103827093B (enExample) |
| AU (1) | AU2012317424B2 (enExample) |
| BR (1) | BR112014007436A2 (enExample) |
| CA (1) | CA2850196A1 (enExample) |
| IL (2) | IL231677A (enExample) |
| IN (1) | IN2014CN02346A (enExample) |
| MX (1) | MX354498B (enExample) |
| RU (2) | RU2630682C2 (enExample) |
| SG (1) | SG11201400974VA (enExample) |
| WO (1) | WO2013047758A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101970509B1 (ko) | 2011-09-28 | 2019-04-19 | 후지필름 가부시키가이샤 | 5-히드록시-1h-이미다졸-4-카르복사미드 수화물의 결정, 5-히드록시-1h-이미다졸-4-카르복사미드·3/4 수화물의 결정 및 그 제조 방법 |
| WO2014112529A1 (ja) * | 2013-01-15 | 2014-07-24 | 富士フイルム株式会社 | 5-ヒドロキシ-1h-イミダゾール-4-カルボキサミドの硫酸塩 |
| JP6294357B2 (ja) | 2014-01-10 | 2018-03-14 | 富士フイルム株式会社 | 5−ヒドロキシ−1h−イミダゾール−4−カルボキサミドの有効投与量または感受性の予測方法および予測装置、キサントシン一リン酸の量の測定方法ならびに骨髄異形成症候群の処置剤および処置方法 |
| WO2018051971A1 (ja) * | 2016-09-13 | 2018-03-22 | 富士フイルム株式会社 | Mll関連白血病の予防または治療のための医薬、方法、使用及び化合物 |
| EP3686189B1 (en) * | 2017-10-27 | 2021-09-01 | FUJIFILM Corporation | Production method for 5-hydroxy-1h-imidazole-4-carboxamide-3/4hydrate |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4181731A (en) * | 1976-09-07 | 1980-01-01 | Sumitomo Chemical Company, Limited | Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole |
| JPS5625165A (en) * | 1979-08-08 | 1981-03-10 | Sumitomo Chem Co Ltd | Novel imidazole derivative |
| JPS5824569A (ja) | 1981-08-05 | 1983-02-14 | Sumitomo Chem Co Ltd | イミダゾ−ル誘導体の精製方法 |
| US4503235A (en) * | 1983-03-11 | 1985-03-05 | Warner-Lambert Company | Process for producing 4-carbamoyl-1H-imidazolium-5-olate |
| JPS60185727A (ja) * | 1984-03-05 | 1985-09-21 | Sumitomo Chem Co Ltd | 4−カルバモイルイミダゾリウム−5−オレ−ト製剤の安定化法 |
| CA2152863A1 (en) | 1994-07-26 | 1996-01-27 | Yeun-Kwei Han | Preparation of acyclovir |
| US5567816A (en) | 1994-07-26 | 1996-10-22 | Syntex (U.S.A.) Inc. | Preparation of acyclovir using 1,3 dioxolane |
| JP2004509948A (ja) | 2000-09-29 | 2004-04-02 | ビーエーエスエフ アクチェンゲゼルシャフト | 1−置換−5−クロロ−4−メチルピラゾールの製造方法 |
| JP2002265601A (ja) | 2001-03-07 | 2002-09-18 | Rikogaku Shinkokai | イミド樹脂 |
| AU2006215567B2 (en) * | 2005-02-16 | 2011-05-12 | Abbott Healthcare Products B.V. | 1H-imidazole derivatives as cannabinoid CB2 receptor modulators |
| UA94737C2 (ru) * | 2006-02-24 | 2011-06-10 | Лексикон Фармасьютикалз, Инк. | Соединения на основе имидазола, композиция, которая их содержит, и их применение |
| JP5266010B2 (ja) * | 2007-09-14 | 2013-08-21 | 富士フイルム株式会社 | 4−カルバモイル−5−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物 |
| KR100982720B1 (ko) * | 2008-02-04 | 2010-09-17 | 주식회사 파마코스텍 | 4-카르바모일-1-β-D-리보푸라노실이미다졸륨-5-올레이트의 생산을 위한 중간체로서의 2-아미노말론아미드의제조방법 |
| KR101970509B1 (ko) | 2011-09-28 | 2019-04-19 | 후지필름 가부시키가이샤 | 5-히드록시-1h-이미다졸-4-카르복사미드 수화물의 결정, 5-히드록시-1h-이미다졸-4-카르복사미드·3/4 수화물의 결정 및 그 제조 방법 |
| JP5726830B2 (ja) | 2011-09-28 | 2015-06-03 | 富士フイルム株式会社 | 5−ヒドロキシ−1h−イミダゾール−4−カルボキサミド・3/4水和物の結晶及びその製造方法 |
-
2012
- 2012-09-28 KR KR1020147008200A patent/KR101970509B1/ko not_active Expired - Fee Related
- 2012-09-28 AU AU2012317424A patent/AU2012317424B2/en not_active Ceased
- 2012-09-28 CA CA2850196A patent/CA2850196A1/en active Pending
- 2012-09-28 WO PCT/JP2012/075106 patent/WO2013047758A1/ja not_active Ceased
- 2012-09-28 BR BR112014007436A patent/BR112014007436A2/pt not_active Application Discontinuation
- 2012-09-28 EP EP12835728.2A patent/EP2762469B1/en not_active Not-in-force
- 2012-09-28 IN IN2346CHN2014 patent/IN2014CN02346A/en unknown
- 2012-09-28 RU RU2014111810A patent/RU2630682C2/ru not_active IP Right Cessation
- 2012-09-28 MX MX2014003638A patent/MX354498B/es active IP Right Grant
- 2012-09-28 SG SG11201400974VA patent/SG11201400974VA/en unknown
- 2012-09-28 RU RU2017125796A patent/RU2672560C1/ru not_active IP Right Cessation
- 2012-09-28 CN CN201280047308.0A patent/CN103827093B/zh not_active Expired - Fee Related
-
2014
- 2014-03-24 IL IL231677A patent/IL231677A/en active IP Right Grant
- 2014-03-26 US US14/226,364 patent/US9108928B2/en active Active
-
2015
- 2015-07-10 US US14/796,602 patent/US9567303B2/en not_active Expired - Fee Related
-
2016
- 2016-07-13 IL IL246754A patent/IL246754A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140069052A (ko) | 2014-06-09 |
| MX2014003638A (es) | 2014-05-21 |
| AU2012317424A1 (en) | 2014-04-17 |
| SG11201400974VA (en) | 2014-09-26 |
| EP2762469A4 (en) | 2015-01-14 |
| WO2013047758A1 (ja) | 2013-04-04 |
| IL246754A (en) | 2017-08-31 |
| IN2014CN02346A (enExample) | 2015-06-19 |
| NZ622928A (en) | 2015-04-24 |
| EP2762469A1 (en) | 2014-08-06 |
| US20140275568A1 (en) | 2014-09-18 |
| EP2762469B1 (en) | 2016-11-23 |
| CN103827093A (zh) | 2014-05-28 |
| CN103827093B (zh) | 2016-06-15 |
| HK1197406A1 (zh) | 2015-01-16 |
| RU2672560C1 (ru) | 2018-11-16 |
| IL231677A0 (en) | 2014-05-28 |
| US9108928B2 (en) | 2015-08-18 |
| AU2012317424B2 (en) | 2017-05-18 |
| AU2012317424A8 (en) | 2014-07-03 |
| US9567303B2 (en) | 2017-02-14 |
| KR101970509B1 (ko) | 2019-04-19 |
| RU2014111810A (ru) | 2015-11-10 |
| IL231677A (en) | 2017-01-31 |
| BR112014007436A2 (pt) | 2017-04-04 |
| RU2630682C2 (ru) | 2017-09-12 |
| CA2850196A1 (en) | 2013-04-04 |
| US20150315156A1 (en) | 2015-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014006992A (es) | Disales de acido malonico y metodo para preparar dihaluros de malonilo. | |
| NZ601805A (en) | Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same | |
| UA116876C2 (uk) | Спосіб одержання хінолінових похідних | |
| NZ718009A (en) | Process for producing diazabicyclooctane derivative and intermediate thereof | |
| PH12016502334B1 (en) | Method for producing fused heterocyclic compound | |
| WO2014026657A3 (en) | A process for the preparation of a derivative of 2-methyl-2'-phenylpropionic acid using new intermediates | |
| EP3560929A3 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same | |
| MX2013011402A (es) | Procedimiento para preparar soluciones acuosas de sales trialcalinometalicas de acido metilglicin - n, n - diacetico. | |
| MX354498B (es) | Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida. | |
| IN2012DN01104A (enExample) | ||
| MX347564B (es) | Proceso para la preparacion de n-metoxi-[1-metil-2-feniletil]amida s del acido 3-difluorometil-1-metil-1h-pirazol-4-carboxilico sustituidas con fenilo. | |
| IN2014DN00144A (enExample) | ||
| WO2012099734A3 (en) | Improved process for preparation of low molecular weight molybdenum succinimide complexes | |
| EA201490998A1 (ru) | Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты | |
| MX2012001722A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
| GB2523674A (en) | Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof | |
| TN2014000329A1 (en) | Method for preparing compound by novel michael addition reaction using water or various acids as additive | |
| IN2015DN02241A (enExample) | ||
| MX2013004193A (es) | Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico. | |
| UA113067C2 (xx) | Спосіб одержання хінолінкарбонової кислоти | |
| EA201300100A2 (ru) | Способ ферментативного синтеза (7s)-3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбоновой кислоты или ее сложных эфиров и применение для синтеза ивабрадина и его соли | |
| UA102091C2 (ru) | Способ получения сульфонилпиролов как ингибиторов hdac | |
| SA112330994B1 (ar) | عملية جديدة لتخليق إيفابردين وأملاح الإضافة الخاصة به مع حمض مقبول صيدلانياً | |
| WO2014203855A3 (ja) | 2-アミノ-2-ヒドロキシイミノ-n-アルコキシアセトイミドイルシアニドの製造方法およびその製造中間体 | |
| MY168434A (en) | Novel acetic acid ester compound or salt thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |